OTV

OTV is a venture capital firm established in 2014, with offices in Tel Aviv, New York City, and Shanghai. The firm focuses on investing in innovative entrepreneurs within the digital health sector, as well as in areas such as big data, mobile technology, and the Internet of Things. OTV aims to support ventures that have the potential to improve lives globally through their products and services.

Amir Lahat

General Partner

Rachely Sitbon

CFO

Manor Zemer

Partner

20 past transactions

Stake

Series A in 2022
Stake enables renters to receive cash back rewards for paying their rent. Stake is on a mission to make renting financially rewarding, build renters’ savings with no fees or debt accumulation, and empower today’s owners to create financially safe and secure rental communities. Stake reduces downtimes and marketing costs while boosting top-line revenue with retention and renewals. Its data-powered rewards lessen the overall cost of incentives and concessions by over 50% and increase leasing velocity by 2x.

Scopio Labs

Series C in 2022
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Aptihealth

Series B in 2021
Aptihealth is a behavioral health engagement company that focuses on enhancing access to mental health services for underserved populations. Its innovative platform integrates physical and behavioral healthcare by connecting patients, medical providers, and behavioral health specialists through proprietary screening, assessment, and treatment management protocols. This digital solution aims to streamline the care process, enabling personalized care delivery and facilitating effective communication among all parties involved. By leveraging technology, Aptihealth seeks to improve patient outcomes and promote faster recovery, ensuring that individuals receive the support they need to maintain better mental health over the long term.

Campfire

Seed Round in 2021
Campfire is a new startup focused on 3D collaboration for design and engineering workflows. Led by pioneers of today’s most well-known augmented reality platforms, Campfire provides a new generation of devices and applications that enable globally distributed teams to work with 3D models as if sharing a central holographic projector.

TytoCare

Series D in 2021
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Medasense

Series C in 2020
Medasense is a company specializing in pain monitoring technology aimed at optimizing and personalizing pain management for patients. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor platform and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL® index. This device is particularly beneficial in operating rooms and critical care settings where patients cannot communicate, addressing a significant market need. Medasense also offers pipeline cloud-based solutions that leverage NOL technology for use in clinics and home care, targeting an even larger global market. The PMD-200 is distributed in Europe by Medtronic and has received clearance for marketing in Canada, Latin America, and Australia, with capabilities for integration with Philips patient monitors. Clinical studies have highlighted its effectiveness in improving patient safety and outcomes while reducing opioid usage. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.

Lemonaid Health

Series B in 2020
Lemonaid Health is an online telemedicine platform founded in 2013 and headquartered in San Francisco, California. The company aims to enhance the patient experience and optimize clinical care by utilizing advancements in machine learning and artificial intelligence. By collecting details about medical history, symptoms, current medications, and allergies, Lemonaid Health employs evidence-based guidelines to provide patients with prescriptions. This approach allows users to access quality healthcare services at a price point lower than typical co-pays, making healthcare more affordable and accessible.

Scopio Labs

Series B in 2020
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

TytoCare

Venture Round in 2020
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

HyGIeaCare

Series C in 2019
HyGIeaCare, Inc. is a healthcare provider specializing in solutions for gastroenterologists, aimed at improving gastrointestinal outcomes for patients in the United States and internationally. Founded in 2014 and based in Austin, Texas, the company offers the HyGIeaCare Prep system, a prescription medical device designed for colon cleansing prior to procedures such as radiologic examinations or endoscopies. Additionally, it provides colon cleansing procedures to help alleviate symptoms of chronic constipation. HyGIeaCare operates a network of centers dedicated to these services, ensuring a simpler and more effective bowel preparation process for patients undergoing colonoscopies.

Emedgene

Series A in 2019
Emedgene offers AI-driven solutions for genomic diagnostics and discovery, collaborating with leading healthcare and life sciences organizations to enhance precision medicine initiatives. The company's genomics intelligence platform automates the interpretation of genetic tests, leveraging an AI engine that analyzes vast amounts of data from patient cases, databases, and recent genomic publications. This innovative approach allows healthcare professionals to deliver personalized care more effectively by improving resolution rates and overall diagnostic yield. Emedgene's technology aims to accelerate research and facilitate high-throughput diagnostics, ultimately advancing the field of genomics.

Harbo Technologies

Series A in 2017
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills through its innovative T-Fence immediate booming system. Founded in 2012 and based in Tel Aviv, Israel, the company has developed a lightweight and efficient oil spill response mechanism that can be deployed by as few as two personnel at the spill source, making it suitable for use on vessels, at ports, or oil terminals. The T-Fence system features a compact vessel that simultaneously produces and deploys an offshore containment boom, effectively blocking the spread of oil spills in various challenging environments. HARBO Technologies aims to serve a diverse range of clients, including oil companies, coast guard units, and marine agriculture sectors, by providing a rapid response solution that minimizes environmental damage and reduces logistical complexities.

Gauzy

Series B in 2016
Gauzy Limited is a leading developer and manufacturer of light control technologies, specializing in liquid crystal films and suspended particle device (SPD) technologies. Established in 2009 and headquartered in Tel Aviv, Israel, Gauzy offers a range of products that enable glass to transition between transparent and opaque states, providing customizable solutions for privacy, shading, and solar control. The company's innovative LCG® (light control glass) technology is utilized in diverse applications, including architecture, automotive, marine vessels, and consumer electronics. With production facilities and R&D centers in Israel and Germany, as well as sales and distribution centers in the USA and global partnerships, Gauzy serves a wide array of industries worldwide. Its clientele includes renowned brands such as Crowne Plaza, Deloitte, and Intel, highlighting the company's significant impact on the integration of smart glazing solutions across various sectors.

Scopio Labs

Venture Round in 2016
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Medasense

Series B in 2016
Medasense is a company specializing in pain monitoring technology aimed at optimizing and personalizing pain management for patients. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor platform and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL® index. This device is particularly beneficial in operating rooms and critical care settings where patients cannot communicate, addressing a significant market need. Medasense also offers pipeline cloud-based solutions that leverage NOL technology for use in clinics and home care, targeting an even larger global market. The PMD-200 is distributed in Europe by Medtronic and has received clearance for marketing in Canada, Latin America, and Australia, with capabilities for integration with Philips patient monitors. Clinical studies have highlighted its effectiveness in improving patient safety and outcomes while reducing opioid usage. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.

Harbo Technologies

Seed Round in 2016
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills through its innovative T-Fence immediate booming system. Founded in 2012 and based in Tel Aviv, Israel, the company has developed a lightweight and efficient oil spill response mechanism that can be deployed by as few as two personnel at the spill source, making it suitable for use on vessels, at ports, or oil terminals. The T-Fence system features a compact vessel that simultaneously produces and deploys an offshore containment boom, effectively blocking the spread of oil spills in various challenging environments. HARBO Technologies aims to serve a diverse range of clients, including oil companies, coast guard units, and marine agriculture sectors, by providing a rapid response solution that minimizes environmental damage and reduces logistical complexities.

mPharma

Seed Round in 2016
mPharma is a healthcare company focused on enhancing access to affordable medications in emerging markets. Founded in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, mPharma collaborates with drug manufacturers, insurance providers, financial institutions, and governments to streamline the delivery of prescription drugs to consumers. The company offers a pharmaceutical data analytics platform that assists pharmacies in managing their inventory, prescribing medications, and reporting adverse drug reactions. By ensuring that high-quality chronic disease medications are consistently available at sustainable prices, mPharma aims to improve health outcomes for patients, doctors, and pharmacists alike.

Via Surgical

Series A in 2016
Via Surgical Ltd. specializes in developing innovative surgical fixation technologies aimed at enhancing hernia repair procedures. Founded in 2011 and based in Amirim, Israel, the company has created FasTouch, a system that facilitates the deployable fixation of sutures, ensuring strong and consistent support during surgical interventions. The design of these lightweight sutures incorporates a closed locked-loop concept, which not only provides effective fixation but also minimizes the amount of material used, potentially reducing foreign body reactions and chronic pain in patients. Via Surgical's offerings extend beyond hernia repair, also encompassing applications in rotator cuff repair using minimally invasive techniques. The founding team, with prior experience at PolyTouch Medical, is committed to advancing soft tissue repair technologies.

Scopio Labs

Series A in 2015
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

CU-BX

Corporate Round in 2015
CU-BX is a health analytics platform focused on enhancing driver safety and in-cabin comfort through advanced monitoring solutions. The company specializes in high-accuracy measurements of critical driver health parameters, including fatigue, stress, and overall comfort levels. Utilizing patented technology, CU-BX's systems deliver precise data regardless of varying road and lighting conditions and are unaffected by clothing or accessories. The platform supports various automotive players, including original equipment manufacturers and component suppliers, by providing driver monitoring systems and aftermarket solutions. CU-BX augments traditional dashcam data with advanced sensors capable of detecting vital signs such as heart rate and respiratory rate, facilitating improved fleet management and safer driving experiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.